Teva Pharmaceutical Industries Limited - Depositary Receipt Price Target Increased by 19.98% to $0.13
Published . Updated .
The average one-year price target for Teva Pharmaceutical Industries Limited - Depositary Receipt (NYSE:TEVA) has been revised to $0.13 / share, up 19.98% from the prior estimate of $0.11 dated September 13, 2026. These figures represent aggregate analyst targets compiled by Fint
Directly affected
- TEVA Teva Pharmaceutical Industries
Named in this report.
Indirectly affected
- JPM JPMorgan Chase
Bank profits move with lending and interest rates
- BAC Bank of America
Bank profits move with lending and interest rates
- WFC Wells Fargo
Bank profits move with lending and interest rates
- C Citigroup
Bank profits move with lending and interest rates
- GS Goldman Sachs
Bank profits move with lending and interest rates
- MS Morgan Stanley
Bank profits move with lending and interest rates
- XLF Financial Select Sector SPDR
A fund of financial companies
- KBE SPDR S&P Bank
A fund of bank stocks
- KRE SPDR S&P Regional Banking
Regional banks are sensitive to deposits and rates
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
The average one-year price target for Teva Pharmaceutical Industries Limited - Depositary Receipt (NYSE:TEVA) has been revised to $0.13 / share, up 19.98% from the prior estimate of $0.11 dated September 13, 2026. These figures represent a…
Source: Nasdaq Markets
The price since 2 Oct 2026: Acadia Healthcare (ACHC) versus the S&P 500
Since the first closing price after “Teva Pharmaceutical Industries Limited - Depositary Receipt Price Target Increased by 19.98% to $0.13,” Acadia Healthcare (ACHC) is +4.50%. The S&P 500 fund (SPY) is -1.08% over the same days, a +5.58% difference versus the market.
Who reported a Acadia Healthcare (ACHC) trade near this story
- Gilbert Cisneros sell BridgeBio Pharma (BBIO) ($1,001 - $15,000). That is 3 days before publication, inside 30 days. The filing is listed beside the story “Teva Pharmaceutical Industries Limited - Depositary Receipt Price Target Increased by 19.98% to $0.13.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 21 days before publication, inside 30 days. The filing is listed beside the story “Teva Pharmaceutical Industries Limited - Depositary Receipt Price Target Increased by 19.98% to $0.13.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 60 days before publication, inside 60 days. The filing is listed beside the story “Teva Pharmaceutical Industries Limited - Depositary Receipt Price Target Increased by 19.98% to $0.13.”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Acadia Healthcare (ACHC)
Companies carried with this story
- ACHC Acadia Healthcare
Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence in the 2 Oct 2026 story “Teva Pharmaceutical Industries Limited - Depositary Receipt Price Target Increased by 19.98% to $0.13.” Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
In “Teva Pharmaceutical Industries Limited - Depositary Receipt Price Target Increased by 19.98% to $0.13,” Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence. Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
In “Teva Pharmaceutical Industries Limited - Depositary Receipt Price Target Increased by 19.98% to $0.13,” aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence. Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
For “Teva Pharmaceutical Industries Limited - Depositary Receipt Price Target Increased by 19.98% to $0.13,” BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence. Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DVA Davita
In “Teva Pharmaceutical Industries Limited - Depositary Receipt Price Target Increased by 19.98% to $0.13,” Davita (DVA) is linked, with no stored direction, medium confidence. Reason on file: GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- GEHC GE HealthCare Technologies
In “Teva Pharmaceutical Industries Limited - Depositary Receipt Price Target Increased by 19.98% to $0.13,” GE HealthCare Technologies (GEHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Acadia Healthcare (ACHC)
The 2 Oct 2026 story “Teva Pharmaceutical Industries Limited - Depositary Receipt Price Target Increased by 19.98% to $0.13” names Acadia Healthcare (ACHC) because of this story.
What ties Acadia Healthcare (ACHC) to the headline is this: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Also listed, Ascendis Pharma A/S (ASND): GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates and price levels for Acadia Healthcare (ACHC)
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ASND traded between 219.69 and 240.84 across 20 sessions. The latest close on file is 229.99. ATYR traded between 0.17 and 0.41 across 20 sessions. The latest close on file is 0.17.
What the saved facts support for Acadia Healthcare (ACHC)
46 out of 100
“Teva Pharmaceutical Industries Limited - Depositary Receipt Price Target Increased by 19.98% to $0.13” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.